vgx-6150
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2014 (NCT02027116)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis C virusImmunity, active
Hepatitis C virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vgx-6150
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02027116 | Phase 1 | Jan 1, 2014 | GeneOne Life Science, Inovio Pharmaceuticals, Pusan National University, Yonsei University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneOne Life Science | For profit | 1 | 1 | 1 | 2014 |
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2014 |
| Pusan National University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1